Karyopharm Therapeutics, Inc. (KPTI)
6.14
+0.25
(+4.24%)
USD |
NASDAQ |
Dec 09, 12:50
Karyopharm Therapeutics Shareholders Equity (Quarterly): -269.26M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 607.22M |
| Actinium Pharmaceuticals, Inc. | 13.78M |
| Axsome Therapeutics, Inc. | 73.73M |
| Krystal Biotech, Inc. | 1.138B |
| Akebia Therapeutics, Inc. | 41.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.23M |
| Total Liabilities (Quarterly) | 365.49M |
| Debt to Equity Ratio | -0.7295 |
| Current Ratio | 1.030 |
| Net Debt Paydown Yield | -0.28% |